nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—SLC15A2—melanoma	0.893	1	CbGaD
Ceftibuten—Rigors—Vemurafenib—melanoma	0.00266	0.0279	CcSEcCtD
Ceftibuten—Nephropathy toxic—Bleomycin—melanoma	0.00229	0.024	CcSEcCtD
Ceftibuten—Drug fever—Docetaxel—melanoma	0.00221	0.0232	CcSEcCtD
Ceftibuten—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00204	0.44	CbGpPWpGaD
Ceftibuten—Nephropathy toxic—Carmustine—melanoma	0.002	0.0209	CcSEcCtD
Ceftibuten—Aphasia—Carmustine—melanoma	0.00177	0.0186	CcSEcCtD
Ceftibuten—Aphasia—Temozolomide—melanoma	0.00171	0.0179	CcSEcCtD
Ceftibuten—Digestion impaired—Temozolomide—melanoma	0.00166	0.0174	CcSEcCtD
Ceftibuten—Cholestasis—Temozolomide—melanoma	0.00146	0.0153	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00142	0.0149	CcSEcCtD
Ceftibuten—Rigors—Temozolomide—melanoma	0.00136	0.0142	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.0012	0.0126	CcSEcCtD
Ceftibuten—Aplastic anaemia—Dactinomycin—melanoma	0.00115	0.0121	CcSEcCtD
Ceftibuten—Cefepime—SLC15A2—melanoma	0.00112	0.167	CrCbGaD
Ceftibuten—Vaginal inflammation—Temozolomide—melanoma	0.00111	0.0116	CcSEcCtD
Ceftibuten—Candida infection—Carmustine—melanoma	0.0011	0.0115	CcSEcCtD
Ceftibuten—Candida infection—Temozolomide—melanoma	0.00106	0.0111	CcSEcCtD
Ceftibuten—Vaginal infection—Temozolomide—melanoma	0.00105	0.011	CcSEcCtD
Ceftibuten—Aplastic anaemia—Temozolomide—melanoma	0.00104	0.0109	CcSEcCtD
Ceftibuten—Erythema multiforme—Vemurafenib—melanoma	0.00103	0.0108	CcSEcCtD
Ceftibuten—Cefuroxime—SLC15A2—melanoma	0.00101	0.151	CrCbGaD
Ceftibuten—Chills—Vemurafenib—melanoma	0.000979	0.0103	CcSEcCtD
Ceftibuten—Dysgeusia—Vemurafenib—melanoma	0.00093	0.00974	CcSEcCtD
Ceftibuten—Rigors—Docetaxel—melanoma	0.000904	0.00947	CcSEcCtD
Ceftibuten—Nasal congestion—Temozolomide—melanoma	0.000885	0.00926	CcSEcCtD
Ceftibuten—Cefixime—SLC15A2—melanoma	0.000875	0.131	CrCbGaD
Ceftibuten—Ceftazidime—SLC15A2—melanoma	0.000823	0.123	CrCbGaD
Ceftibuten—Cefdinir—SLC15A2—melanoma	0.000807	0.121	CrCbGaD
Ceftibuten—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000802	0.0084	CcSEcCtD
Ceftibuten—Pancytopenia—Bleomycin—melanoma	0.000784	0.00821	CcSEcCtD
Ceftibuten—Anaphylactic shock—Vemurafenib—melanoma	0.000775	0.00812	CcSEcCtD
Ceftibuten—Dehydration—Temozolomide—melanoma	0.000749	0.00785	CcSEcCtD
Ceftibuten—Pancytopenia—Dactinomycin—melanoma	0.000731	0.00766	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000726	0.0076	CcSEcCtD
Ceftibuten—Neutropenia—Dactinomycin—melanoma	0.00072	0.00754	CcSEcCtD
Ceftibuten—Candida infection—Docetaxel—melanoma	0.000705	0.00738	CcSEcCtD
Ceftibuten—Haematuria—Bleomycin—melanoma	0.000702	0.00735	CcSEcCtD
Ceftibuten—Pancytopenia—Carmustine—melanoma	0.000684	0.00717	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000681	0.00713	CcSEcCtD
Ceftibuten—Neutropenia—Carmustine—melanoma	0.000674	0.00706	CcSEcCtD
Ceftibuten—Decreased appetite—Vemurafenib—melanoma	0.000674	0.00706	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Vemurafenib—melanoma	0.000669	0.00701	CcSEcCtD
Ceftibuten—Fatigue—Vemurafenib—melanoma	0.000668	0.007	CcSEcCtD
Ceftibuten—Haemoglobin—Bleomycin—melanoma	0.000664	0.00696	CcSEcCtD
Ceftibuten—Constipation—Vemurafenib—melanoma	0.000663	0.00694	CcSEcCtD
Ceftibuten—Pancytopenia—Temozolomide—melanoma	0.000661	0.00693	CcSEcCtD
Ceftibuten—Haemorrhage—Bleomycin—melanoma	0.000661	0.00692	CcSEcCtD
Ceftibuten—Dysuria—Temozolomide—melanoma	0.000651	0.00682	CcSEcCtD
Ceftibuten—Neutropenia—Temozolomide—melanoma	0.000651	0.00682	CcSEcCtD
Ceftibuten—Agranulocytosis—Dactinomycin—melanoma	0.000641	0.00671	CcSEcCtD
Ceftibuten—Cefotaxime—SLC15A2—melanoma	0.000633	0.0946	CrCbGaD
Ceftibuten—Renal failure—Carmustine—melanoma	0.000632	0.00662	CcSEcCtD
Ceftibuten—Ceftriaxone—SLC15A2—melanoma	0.000623	0.0932	CrCbGaD
Ceftibuten—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000616	0.00645	CcSEcCtD
Ceftibuten—Body temperature increased—Vemurafenib—melanoma	0.000613	0.00642	CcSEcCtD
Ceftibuten—Chills—Bleomycin—melanoma	0.000593	0.00621	CcSEcCtD
Ceftibuten—Erythema multiforme—Dactinomycin—melanoma	0.000583	0.0061	CcSEcCtD
Ceftibuten—Haemoglobin—Carmustine—melanoma	0.00058	0.00607	CcSEcCtD
Ceftibuten—Haemorrhage—Carmustine—melanoma	0.000577	0.00604	CcSEcCtD
Ceftibuten—Hypersensitivity—Vemurafenib—melanoma	0.000571	0.00598	CcSEcCtD
Ceftibuten—Renal impairment—Docetaxel—melanoma	0.000563	0.0059	CcSEcCtD
Ceftibuten—Haemoglobin—Temozolomide—melanoma	0.00056	0.00587	CcSEcCtD
Ceftibuten—Haemorrhage—Temozolomide—melanoma	0.000557	0.00584	CcSEcCtD
Ceftibuten—Asthenia—Vemurafenib—melanoma	0.000556	0.00582	CcSEcCtD
Ceftibuten—Chills—Dactinomycin—melanoma	0.000553	0.00579	CcSEcCtD
Ceftibuten—Pruritus—Vemurafenib—melanoma	0.000548	0.00574	CcSEcCtD
Ceftibuten—Cefalotin—SLC15A2—melanoma	0.000546	0.0816	CrCbGaD
Ceftibuten—Diarrhoea—Vemurafenib—melanoma	0.00053	0.00555	CcSEcCtD
Ceftibuten—Erythema multiforme—Temozolomide—melanoma	0.000527	0.00552	CcSEcCtD
Ceftibuten—Dizziness—Vemurafenib—melanoma	0.000512	0.00537	CcSEcCtD
Ceftibuten—Chills—Temozolomide—melanoma	0.0005	0.00524	CcSEcCtD
Ceftibuten—Dehydration—Docetaxel—melanoma	0.000498	0.00522	CcSEcCtD
Ceftibuten—Vomiting—Vemurafenib—melanoma	0.000493	0.00516	CcSEcCtD
Ceftibuten—Rash—Vemurafenib—melanoma	0.000489	0.00512	CcSEcCtD
Ceftibuten—Dermatitis—Vemurafenib—melanoma	0.000488	0.00511	CcSEcCtD
Ceftibuten—Headache—Vemurafenib—melanoma	0.000485	0.00508	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000483	0.00505	CcSEcCtD
Ceftibuten—Dysgeusia—Temozolomide—melanoma	0.000475	0.00498	CcSEcCtD
Ceftibuten—Anaphylactic shock—Bleomycin—melanoma	0.00047	0.00492	CcSEcCtD
Ceftibuten—Agitation—Carmustine—melanoma	0.000461	0.00483	CcSEcCtD
Ceftibuten—Nausea—Vemurafenib—melanoma	0.00046	0.00482	CcSEcCtD
Ceftibuten—Anorexia—Bleomycin—melanoma	0.000448	0.00469	CcSEcCtD
Ceftibuten—Agitation—Temozolomide—melanoma	0.000446	0.00467	CcSEcCtD
Ceftibuten—Pancytopenia—Docetaxel—melanoma	0.00044	0.00461	CcSEcCtD
Ceftibuten—Convulsion—Carmustine—melanoma	0.000435	0.00456	CcSEcCtD
Ceftibuten—Neutropenia—Docetaxel—melanoma	0.000433	0.00454	CcSEcCtD
Ceftibuten—Paraesthesia—Bleomycin—melanoma	0.000422	0.00442	CcSEcCtD
Ceftibuten—Convulsion—Temozolomide—melanoma	0.00042	0.0044	CcSEcCtD
Ceftibuten—Dyspnoea—Bleomycin—melanoma	0.000419	0.00438	CcSEcCtD
Ceftibuten—Anorexia—Dactinomycin—melanoma	0.000417	0.00437	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000409	0.00429	CcSEcCtD
Ceftibuten—Decreased appetite—Bleomycin—melanoma	0.000408	0.00427	CcSEcCtD
Ceftibuten—Renal failure—Docetaxel—melanoma	0.000406	0.00425	CcSEcCtD
Ceftibuten—Dry mouth—Temozolomide—melanoma	0.000404	0.00423	CcSEcCtD
Ceftibuten—Jaundice—Docetaxel—melanoma	0.000403	0.00422	CcSEcCtD
Ceftibuten—Anaphylactic shock—Temozolomide—melanoma	0.000396	0.00415	CcSEcCtD
Ceftibuten—Anorexia—Carmustine—melanoma	0.000391	0.00409	CcSEcCtD
Ceftibuten—Agranulocytosis—Docetaxel—melanoma	0.000385	0.00404	CcSEcCtD
Ceftibuten—Decreased appetite—Dactinomycin—melanoma	0.000381	0.00399	CcSEcCtD
Ceftibuten—Fatigue—Dactinomycin—melanoma	0.000378	0.00395	CcSEcCtD
Ceftibuten—Anorexia—Temozolomide—melanoma	0.000378	0.00395	CcSEcCtD
Ceftibuten—Urticaria—Bleomycin—melanoma	0.000373	0.00391	CcSEcCtD
Ceftibuten—Haemoglobin—Docetaxel—melanoma	0.000373	0.0039	CcSEcCtD
Ceftibuten—Body temperature increased—Bleomycin—melanoma	0.000371	0.00389	CcSEcCtD
Ceftibuten—Haemorrhage—Docetaxel—melanoma	0.000371	0.00388	CcSEcCtD
Ceftibuten—Insomnia—Carmustine—melanoma	0.000371	0.00388	CcSEcCtD
Ceftibuten—Paraesthesia—Carmustine—melanoma	0.000368	0.00385	CcSEcCtD
Ceftibuten—Dyspnoea—Carmustine—melanoma	0.000365	0.00383	CcSEcCtD
Ceftibuten—Somnolence—Carmustine—melanoma	0.000364	0.00382	CcSEcCtD
Ceftibuten—Insomnia—Temozolomide—melanoma	0.000358	0.00375	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Dactinomycin—melanoma	0.000358	0.00375	CcSEcCtD
Ceftibuten—Decreased appetite—Carmustine—melanoma	0.000356	0.00373	CcSEcCtD
Ceftibuten—Paraesthesia—Temozolomide—melanoma	0.000356	0.00372	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Carmustine—melanoma	0.000354	0.00371	CcSEcCtD
Ceftibuten—Dyspnoea—Temozolomide—melanoma	0.000353	0.0037	CcSEcCtD
Ceftibuten—Somnolence—Temozolomide—melanoma	0.000352	0.00369	CcSEcCtD
Ceftibuten—Erythema multiforme—Docetaxel—melanoma	0.000351	0.00367	CcSEcCtD
Ceftibuten—Constipation—Carmustine—melanoma	0.00035	0.00367	CcSEcCtD
Ceftibuten—Dyspepsia—Temozolomide—melanoma	0.000349	0.00365	CcSEcCtD
Ceftibuten—Body temperature increased—Dactinomycin—melanoma	0.000346	0.00363	CcSEcCtD
Ceftibuten—Abdominal pain—Dactinomycin—melanoma	0.000346	0.00363	CcSEcCtD
Ceftibuten—Hypersensitivity—Bleomycin—melanoma	0.000346	0.00362	CcSEcCtD
Ceftibuten—Decreased appetite—Temozolomide—melanoma	0.000344	0.00361	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Temozolomide—melanoma	0.000342	0.00358	CcSEcCtD
Ceftibuten—Fatigue—Temozolomide—melanoma	0.000341	0.00358	CcSEcCtD
Ceftibuten—Constipation—Temozolomide—melanoma	0.000339	0.00355	CcSEcCtD
Ceftibuten—Asthenia—Bleomycin—melanoma	0.000337	0.00353	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Carmustine—melanoma	0.000335	0.00351	CcSEcCtD
Ceftibuten—Chills—Docetaxel—melanoma	0.000333	0.00348	CcSEcCtD
Ceftibuten—Pruritus—Bleomycin—melanoma	0.000332	0.00348	CcSEcCtD
Ceftibuten—Abdominal pain—Carmustine—melanoma	0.000324	0.00339	CcSEcCtD
Ceftibuten—Body temperature increased—Carmustine—melanoma	0.000324	0.00339	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Temozolomide—melanoma	0.000324	0.00339	CcSEcCtD
Ceftibuten—Hypersensitivity—Dactinomycin—melanoma	0.000323	0.00338	CcSEcCtD
Ceftibuten—Dysgeusia—Docetaxel—melanoma	0.000316	0.00331	CcSEcCtD
Ceftibuten—Urticaria—Temozolomide—melanoma	0.000315	0.0033	CcSEcCtD
Ceftibuten—Asthenia—Dactinomycin—melanoma	0.000314	0.00329	CcSEcCtD
Ceftibuten—Abdominal pain—Temozolomide—melanoma	0.000313	0.00328	CcSEcCtD
Ceftibuten—Body temperature increased—Temozolomide—melanoma	0.000313	0.00328	CcSEcCtD
Ceftibuten—Hypersensitivity—Carmustine—melanoma	0.000302	0.00316	CcSEcCtD
Ceftibuten—Diarrhoea—Dactinomycin—melanoma	0.0003	0.00314	CcSEcCtD
Ceftibuten—Vomiting—Bleomycin—melanoma	0.000299	0.00313	CcSEcCtD
Ceftibuten—Rash—Bleomycin—melanoma	0.000296	0.0031	CcSEcCtD
Ceftibuten—Dermatitis—Bleomycin—melanoma	0.000296	0.0031	CcSEcCtD
Ceftibuten—Asthenia—Carmustine—melanoma	0.000294	0.00308	CcSEcCtD
Ceftibuten—Hypersensitivity—Temozolomide—melanoma	0.000292	0.00306	CcSEcCtD
Ceftibuten—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000285	0.0614	CbGpPWpGaD
Ceftibuten—Asthenia—Temozolomide—melanoma	0.000284	0.00298	CcSEcCtD
Ceftibuten—Diarrhoea—Carmustine—melanoma	0.00028	0.00294	CcSEcCtD
Ceftibuten—Pruritus—Temozolomide—melanoma	0.00028	0.00293	CcSEcCtD
Ceftibuten—Convulsion—Docetaxel—melanoma	0.00028	0.00293	CcSEcCtD
Ceftibuten—Nausea—Bleomycin—melanoma	0.000279	0.00292	CcSEcCtD
Ceftibuten—Vomiting—Dactinomycin—melanoma	0.000278	0.00292	CcSEcCtD
Ceftibuten—Rash—Dactinomycin—melanoma	0.000276	0.00289	CcSEcCtD
Ceftibuten—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.000275	0.0592	CbGpPWpGaD
Ceftibuten—Dizziness—Carmustine—melanoma	0.000271	0.00284	CcSEcCtD
Ceftibuten—Diarrhoea—Temozolomide—melanoma	0.000271	0.00284	CcSEcCtD
Ceftibuten—Dry mouth—Docetaxel—melanoma	0.000269	0.00281	CcSEcCtD
Ceftibuten—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000265	0.057	CbGpPWpGaD
Ceftibuten—Anaphylactic shock—Docetaxel—melanoma	0.000263	0.00276	CcSEcCtD
Ceftibuten—Dizziness—Temozolomide—melanoma	0.000262	0.00274	CcSEcCtD
Ceftibuten—Vomiting—Carmustine—melanoma	0.000261	0.00273	CcSEcCtD
Ceftibuten—Nausea—Dactinomycin—melanoma	0.00026	0.00272	CcSEcCtD
Ceftibuten—Rash—Carmustine—melanoma	0.000258	0.00271	CcSEcCtD
Ceftibuten—Dermatitis—Carmustine—melanoma	0.000258	0.0027	CcSEcCtD
Ceftibuten—Headache—Carmustine—melanoma	0.000257	0.00269	CcSEcCtD
Ceftibuten—Vomiting—Temozolomide—melanoma	0.000252	0.00264	CcSEcCtD
Ceftibuten—Anorexia—Docetaxel—melanoma	0.000251	0.00263	CcSEcCtD
Ceftibuten—Rash—Temozolomide—melanoma	0.00025	0.00262	CcSEcCtD
Ceftibuten—Dermatitis—Temozolomide—melanoma	0.000249	0.00261	CcSEcCtD
Ceftibuten—Headache—Temozolomide—melanoma	0.000248	0.0026	CcSEcCtD
Ceftibuten—Nausea—Carmustine—melanoma	0.000243	0.00255	CcSEcCtD
Ceftibuten—Insomnia—Docetaxel—melanoma	0.000238	0.0025	CcSEcCtD
Ceftibuten—Paraesthesia—Docetaxel—melanoma	0.000236	0.00248	CcSEcCtD
Ceftibuten—Nausea—Temozolomide—melanoma	0.000235	0.00246	CcSEcCtD
Ceftibuten—Dyspnoea—Docetaxel—melanoma	0.000235	0.00246	CcSEcCtD
Ceftibuten—Somnolence—Docetaxel—melanoma	0.000234	0.00245	CcSEcCtD
Ceftibuten—Dyspepsia—Docetaxel—melanoma	0.000232	0.00243	CcSEcCtD
Ceftibuten—Decreased appetite—Docetaxel—melanoma	0.000229	0.0024	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Docetaxel—melanoma	0.000227	0.00238	CcSEcCtD
Ceftibuten—Fatigue—Docetaxel—melanoma	0.000227	0.00238	CcSEcCtD
Ceftibuten—Constipation—Docetaxel—melanoma	0.000225	0.00236	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Docetaxel—melanoma	0.000215	0.00226	CcSEcCtD
Ceftibuten—Abdominal pain—Docetaxel—melanoma	0.000208	0.00218	CcSEcCtD
Ceftibuten—Body temperature increased—Docetaxel—melanoma	0.000208	0.00218	CcSEcCtD
Ceftibuten—Hypersensitivity—Docetaxel—melanoma	0.000194	0.00203	CcSEcCtD
Ceftibuten—Asthenia—Docetaxel—melanoma	0.000189	0.00198	CcSEcCtD
Ceftibuten—Pruritus—Docetaxel—melanoma	0.000186	0.00195	CcSEcCtD
Ceftibuten—Diarrhoea—Docetaxel—melanoma	0.00018	0.00189	CcSEcCtD
Ceftibuten—Dizziness—Docetaxel—melanoma	0.000174	0.00182	CcSEcCtD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000168	0.0362	CbGpPWpGaD
Ceftibuten—Vomiting—Docetaxel—melanoma	0.000167	0.00175	CcSEcCtD
Ceftibuten—Rash—Docetaxel—melanoma	0.000166	0.00174	CcSEcCtD
Ceftibuten—Dermatitis—Docetaxel—melanoma	0.000166	0.00174	CcSEcCtD
Ceftibuten—Headache—Docetaxel—melanoma	0.000165	0.00173	CcSEcCtD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000162	0.0349	CbGpPWpGaD
Ceftibuten—Nausea—Docetaxel—melanoma	0.000156	0.00164	CcSEcCtD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000156	0.0336	CbGpPWpGaD
Ceftibuten—Ceftriaxone—ALB—melanoma	0.000134	0.0201	CrCbGaD
Ceftibuten—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000119	0.0255	CbGpPWpGaD
Ceftibuten—Cefalotin—ALB—melanoma	0.000118	0.0176	CrCbGaD
Ceftibuten—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.00011	0.0237	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	7.55e-05	0.0162	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	7.51e-05	0.0162	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	7.24e-05	0.0156	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	7.01e-05	0.0151	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	6.98e-05	0.015	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	6.97e-05	0.015	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	6.82e-05	0.0147	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	6.48e-05	0.0139	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	6.33e-05	0.0136	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	5.23e-05	0.0113	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	4.86e-05	0.0104	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	3.82e-05	0.00821	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	3.68e-05	0.00792	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	3.54e-05	0.00762	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	3.47e-05	0.00746	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	3.22e-05	0.00692	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	3.12e-05	0.00671	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	2.89e-05	0.00623	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	1.59e-05	0.00341	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	1.49e-05	0.0032	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.47e-05	0.00317	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	1.38e-05	0.00297	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	1.21e-05	0.0026	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	1.12e-05	0.00241	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	7.56e-06	0.00163	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	7.02e-06	0.00151	CbGpPWpGaD
